Evidence map›Paper›PMID 28029010›Full record

ArticleAnnals of laboratory medicine2017

Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia.

Nae Yu, Saeam Shin, Jong Rak Choi, Yoonjung Kim, Kyung A Lee

Open access · diamondAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of laboratory medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nae YuDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Saeam ShinDepartment of Laboratory Medicine, Hallym University College of Medicine, Kangnam Sacred Heart Hospital, Seoul, Korea.
Jong Rak ChoiDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Yoonjung KimDepartment of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
Kyung A LeeDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. KAL1119@yuhs.ac.
Yonsei University · KRHallym University Kangnam Sacred Heart Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedCytidine DeaminaseDasatinibDisease ProgressionDrug Resistance, NeoplasmFusion Proteins, bcr-ablHumansImatinib MesylateIn Situ Hybridization, FluorescenceKaryotypeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMicrofilament ProteinsOncogene ProteinsProtein Kinase InhibitorsBCL7A protein, humanBCR-ABL1 fusion protein, humanCytidine DeaminaseDasatinibFusion Proteins, bcr-ablImatinib MesylateMicrofilament ProteinsOncogene ProteinsProtein Kinase Inhibitors

Identifiers

PMID28029010
PMCPMC5204001
OpenAlexW2567595072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.